Soliris (eculizumab) and Ultomiris (ravulizumab-cwvz) are generally safe and effective for easing symptoms of generalized myasthenia gravis (gMG) when used in everyday clinical practice. That’s according to data from the […] The post Registry data back Soliris, Ultomiris as safe, effective for gMG appeared first on Myasthenia Gravis News.
